AOD9604 5AD 5mg*10vials

AOD9604 5AD 5mg*10 vials is an upgraded, highly efficient lyophilized lipolysis research peptide. Based on the classic AOD9604, it is optimized using a unique 5AD advanced molecular modification technology. As an enhanced iteration of the 2AD version, the structural upgrade of 5AD further improves molecular affinity, anti-degradation properties, and fat-targeting specificity, thus endowing it with stronger and more stable lipolysis bioactivity. This product uses a standardized 5mg medium-high concentration specification, perfectly suited for medium-dose gradient experiments, efficient fat metabolism mechanism research, short-term high-intensity metabolic intervention, and efficacy verification of fat remodeling. It is a high-quality core research material for preclinical obesity mechanism research, lipid deposition regulation, and adipose tissue browning research.

Product Functions and Research Value

AOD9604 5AD has the characteristic of potently targeting and activating lipid metabolism without interfering with normal endocrine levels or appetite regulation mechanisms. In laboratory studies, 5AD can effectively activate the adipocyte catabolism pathway, significantly accelerate the oxidative decomposition of subcutaneous and visceral refractory fat, and inhibit the continuous proliferation of adipocytes and abnormal lipid accumulation. Compared to the low-dose version of 2AD, 5AD exhibits stronger lipolysis efficacy and more significant experimental phenotypes, effectively validating lipid metabolism remodeling. It is ideally suited for in-depth research into refractory obesity, correction of lipid metabolism disorders, adipose browning, and exploring the efficacy threshold of medium-dose therapy. The upgraded 5AD molecular structure ensures higher in vivo stability and lower non-specific binding, providing highly stable, specific, and reproducible core data for preclinical studies of lipid metabolism.

Core Product Advantages

1. Advanced Enhanced 5AD Structure: An upgraded iteration based on 2AD modification technology, featuring an optimized molecular stereostructure, stronger lipid-targeting binding affinity, and excellent anti-attenuation capabilities. Compared to the standard AOD9604 and 2AD versions, this product offers more concentrated and efficient lipolysis activity, effectively enhancing the significance of experimental phenotypes.

2. Standard Enhanced Concentration of 5mg: Optimized for medium- to high-dose formulations, addressing the insufficient efficacy of the low-dose version. Suitable for medium- to high-dose gradient screening and high-efficiency metabolic intervention experiments, perfectly balancing experimental safety and phenotypic significance. 3. Purely Targeted Lipolysis Mechanism: An independent lipid metabolism pathway that does not interfere with hunger hormones and basal appetite, achieving pure regulation of adipocyte metabolism, suitable for differentiated research on lipolysis and lipid improvement mechanisms.

4. High-Purity Lyophilization Process: Utilizes aseptic vacuum lyophilization technology to completely lock in peptide activity. Each batch undergoes rigorous HPLC purity testing and comes with an official Certificate of Account (COA), with extremely low impurity content and stable batch consistency.

5. Standardized 10-Vessel Bulk Packaging: 10 vials per box, using integrated aseptic packaging, meeting the needs of long-term laboratory storage, university lipid metabolism research projects, preclinical drug development, and large-scale wholesale procurement.

AOD9604 5AD 5mg*10 vials is an advanced, highly efficient lipid-thawing peptide suitable for research applications. Based on classic AOD9604 and incorporating unique 5AD advanced molecular modification technology, it is an upgraded version of the 2AD formulation. The 5AD structure has been comprehensively optimized, enhancing molecular affinity, anti-degradation properties, and precise fat targeting, resulting in stronger lipolytic activity, more stable efficacy, and more significant experimental phenotypes. AOD9604 5AD peptide at a standard concentration of 5 mg is perfectly suited for advanced research scenarios such as medium-dose gradient experiments, studies of efficient lipid metabolism mechanisms, short-term high-intensity metabolic interventions, and validation of fat remodeling efficacy. It is a high-quality, high-end core research ingredient for preclinical studies of obesity mechanisms, lipid deposition regulation, and adipose browning.

Core Uses and Research Value of the Peptide

AOD9604 5AD peptide possesses a powerful ability to target lipid metabolism activation without interfering with normal endocrine levels or relying on appetite suppression for metabolic regulation. Studies have shown that it can effectively initiate adipocyte catabolism pathways, significantly accelerate the oxidative decomposition of stubborn subcutaneous and visceral fat, and inhibit adipocyte growth.